These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
942 related articles for article (PubMed ID: 33715385)
1. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19. Cai Q; Yin F; Hao L; Jiang W Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385 [TBL] [Abstract][Full Text] [Related]
2. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19. Cheng X; Jiang M; Long L; Meng J Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217 [No Abstract] [Full Text] [Related]
3. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm. Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320 [TBL] [Abstract][Full Text] [Related]
4. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19. Gu J; Zhao Q; Han Z; Han Z Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019. Zayed M; Iohara K Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics. Yadav P; Vats R; Bano A; Bhardwaj R Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279 [TBL] [Abstract][Full Text] [Related]
7. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19. Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770 [TBL] [Abstract][Full Text] [Related]
8. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect. Can A; Coskun H Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878 [TBL] [Abstract][Full Text] [Related]
9. Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals. Vishnupriya M; Naveenkumar M; Manjima K; Sooryasree NV; Saranya T; Ramya S; Harysh Winster S; Paulpandi M; Balachandar V; Arul N Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2748-2751. PubMed ID: 33829461 [TBL] [Abstract][Full Text] [Related]
10. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients. Al-Khawaga S; Abdelalim EM Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell therapy for severe COVID-19. Shi L; Wang L; Xu R; Zhang C; Xie Y; Liu K; Li T; Hu W; Zhen C; Wang FS Signal Transduct Target Ther; 2021 Sep; 6(1):339. PubMed ID: 34497264 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell research progress for the treatment of COVID-19. Yao D; Ye H; Huo Z; Wu L; Wei S J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277 [TBL] [Abstract][Full Text] [Related]
14. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments. Gurunathan S; Kang MH; Kim JH Front Immunol; 2021; 12():716407. PubMed ID: 34394121 [TBL] [Abstract][Full Text] [Related]
15. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review. Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652 [TBL] [Abstract][Full Text] [Related]
16. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment. Wang XY Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities. Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694 [TBL] [Abstract][Full Text] [Related]
18. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs. Jamshidi E; Babajani A; Soltani P; Niknejad H Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential. Xiong J; Bao L; Qi H; Feng Z; Shi Y Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246 [TBL] [Abstract][Full Text] [Related]
20. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients. Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]